The introduction of nicotinamide for a nicotine alternative in e-cigarette and smokeless merchandise represents a big regulatory challenge with the FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to act as a sedative at high dosages6. The statements created by Nicotine River, ECBlend, and various suppliers that t